PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE

PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE was reported 6026 times

PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DISTAL ILEAL OBSTRUCTION SYNDROME 3 0.2143
1 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 4 0.1600
2 MECONIUM PLUG SYNDROME 3 0.1250
3 FAECAL ELASTASE CONCENTRATION ABNORMAL 2 0.1111
4 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 451 0.0828
5 CYSTIC FIBROSIS LUNG 9 0.0703
6 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 61 0.0683
7 CYSTIC FIBROSIS 287 0.0518
8 INABILITY TO CRAWL 3 0.0517
9 DISTAL INTESTINAL OBSTRUCTION SYNDROME 14 0.0415
10 CYSTIC FIBROSIS RELATED DIABETES 6 0.0411
11 PRODUCT INFORMATION CONTENT COMPLAINT 7 0.0251
12 CATHETERISATION VENOUS 2 0.0244
13 INFECTIVE EXACERBATION OF BRONCHIECTASIS 7 0.0228
14 NASAL FLARING 3 0.0222
15 PULMONARY FUNCTION TEST DECREASED 87 0.0199
16 PANCREATIC FAILURE 30 0.0170
17 PANCREATECTOMY 9 0.0161
18 POSTPRANDIAL HYPOGLYCAEMIA 3 0.0160
19 CYSTIC LUNG DISEASE 2 0.0141
20 PANCREATIC INSUFFICIENCY 5 0.0140
21 FORCED EXPIRATORY VOLUME ABNORMAL 2 0.0138
22 TRAUMATIC LIVER INJURY 3 0.0128
23 DEVICE DEPENDENCE 2 0.0127
24 PANCREATOLITHIASIS 5 0.0125
25 PSEUDOMONAS TEST POSITIVE 10 0.0122
26 PANCREATIC ATROPHY 5 0.0114
27 FEEDING TUBE USER 4 0.0109
28 LUNG INFECTION PSEUDOMONAL 6 0.0108
29 STEATORRHOEA 26 0.0097
30 EXPOSURE TO FUNGUS 2 0.0093
31 INFLUENZA A VIRUS TEST POSITIVE 4 0.0093
32 HAEMORRHAGIC DIATHESIS 31 0.0087
33 LUNG TRANSPLANT 30 0.0085
34 BRONCHOSCOPY 2 0.0084
35 DUMPING SYNDROME 2 0.0076
36 CARBOHYDRATE ANTIGEN 19-9 INCREASED 4 0.0076
37 SINUS OPERATION 18 0.0075
38 PANCREAS INFECTION 3 0.0075
39 AMMONIA ABNORMAL 3 0.0074
40 SPUTUM INCREASED 16 0.0074
41 CATHETER SITE THROMBOSIS 2 0.0073
42 PRODUCT PACKAGING DIFFICULT TO OPEN 19 0.0073
43 USE OF ACCESSORY RESPIRATORY MUSCLES 3 0.0073
44 PANCREATITIS CHRONIC 17 0.0072
45 TRANSPLANTATION COMPLICATION 3 0.0071
46 DAIRY INTOLERANCE 2 0.0071
47 PULMONARY FUNCTION TEST ABNORMAL 11 0.0071
48 DYSPHORIA 34 0.0067
49 DUODENAL OBSTRUCTION 2 0.0067
50 ARTHRITIS INFECTIVE 30 0.0065
51 FORCED EXPIRATORY VOLUME DECREASED 18 0.0063
52 INCREASED VISCOSITY OF BRONCHIAL SECRETION 4 0.0063
53 PNEUMOTHORAX SPONTANEOUS 4 0.0059
54 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 3 0.0059
55 APPETITE DISORDER 38 0.0057
56 DERMATITIS DIAPER 4 0.0057
57 PSEUDOMONAS INFECTION 48 0.0056
58 ENZYME ABNORMALITY 3 0.0056
59 OTITIS MEDIA ACUTE 4 0.0054
60 INABILITY TO AFFORD MEDICATION 52 0.0052
61 MOTOR DEVELOPMENTAL DELAY 3 0.0052
62 SKIN WARM 30 0.0052
63 DEPENDENCE ON RESPIRATOR 2 0.0050
64 PANCREATITIS RELAPSING 4 0.0049
65 PANCREATIC DISORDER 23 0.0047
66 CARBON MONOXIDE POISONING 2 0.0047
67 PNEUMONIA PSEUDOMONAL 7 0.0046
68 PANCREATICODUODENECTOMY 3 0.0045
69 BODY MASS INDEX DECREASED 2 0.0043
70 MYCOBACTERIUM ABSCESSUS INFECTION 3 0.0042
71 FAECAL VOLUME DECREASED 2 0.0042
72 BACTERIAL DISEASE CARRIER 3 0.0041
73 RHINOVIRUS INFECTION 16 0.0041
74 UNDERWEIGHT 8 0.0041
75 BRONCHIAL SECRETION RETENTION 5 0.0039
76 ABNORMAL FAECES 32 0.0039
77 ADENOCARCINOMA PANCREAS 5 0.0039
78 PANCREATIC PSEUDOCYST 3 0.0039
79 PANCREATIC CARCINOMA METASTATIC 11 0.0039
80 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 3 0.0038
81 STAPHYLOCOCCUS TEST POSITIVE 8 0.0038
82 NASAL INFLAMMATION 4 0.0038
83 PLACENTAL INSUFFICIENCY 3 0.0037
84 SPUTUM CULTURE POSITIVE 3 0.0037
85 NEONATAL HYPOXIA 3 0.0036
86 TENDERNESS 37 0.0035
87 CARDIORENAL SYNDROME 2 0.0035
88 ENTEROVIRUS INFECTION 3 0.0035
89 BLOOD OESTROGEN INCREASED 2 0.0034
90 GASTRIC OPERATION 3 0.0033
91 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 3 0.0032
92 DIAPHRAGMATIC HERNIA 2 0.0032
93 CORTISOL INCREASED 2 0.0032
94 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
95 CHALAZION 2 0.0031
96 DEVICE BATTERY ISSUE 2 0.0030
97 CHANGE OF BOWEL HABIT 6 0.0029
98 INTENTIONAL UNDERDOSE 21 0.0029
99 ALPHA 1 FOETOPROTEIN INCREASED 2 0.0028
100 PANCREATIC MASS 3 0.0028
101 GASTROINTESTINAL TUBE INSERTION 7 0.0028
102 BRONCHIAL WALL THICKENING 2 0.0028
103 PANCREATIC ENZYMES INCREASED 4 0.0027
104 BILIARY DILATATION 4 0.0027
105 GASTROINTESTINAL WALL THICKENING 4 0.0027
106 BRONCHITIS BACTERIAL 2 0.0026
107 ANIMAL BITE 7 0.0026
108 CROUP INFECTIOUS 2 0.0025
109 FOREIGN BODY IN THROAT 8 0.0025
110 PNEUMONIA STAPHYLOCOCCAL 5 0.0025
111 LUNG INFECTION 39 0.0025
112 HAEMOPTYSIS 70 0.0025
113 WEIGHT ABNORMAL 6 0.0025
114 MALABSORPTION 13 0.0025
115 CHRONIC SINUSITIS 9 0.0024
116 PRODUCT DISPENSING ISSUE 10 0.0023
117 MYCOBACTERIAL INFECTION 4 0.0023
118 RESPIRATION ABNORMAL 16 0.0023
119 INFUSION SITE BRUISING 5 0.0023
120 FLATULENCE 129 0.0023
121 OESOPHAGEAL HAEMORRHAGE 3 0.0023
122 INTERCEPTED PRODUCT PRESCRIBING ERROR 3 0.0023
123 HYPOVITAMINOSIS 3 0.0023
124 FAECES PALE 5 0.0022
125 INTESTINAL OBSTRUCTION 84 0.0022
126 PANCREATITIS NECROTISING 5 0.0022
127 HOSPITALISATION 329 0.0021
128 CATHETER SITE SWELLING 2 0.0021
129 PARANASAL SINUS DISCOMFORT 8 0.0021
130 BLOOD ELECTROLYTES DECREASED 3 0.0021
131 PANCREATIC CYST 4 0.0021
132 PHOTOPHOBIA 39 0.0021
133 ANTIBIOTIC THERAPY 2 0.0020
134 EAR PAIN 39 0.0020
135 DISEASE COMPLICATION 9 0.0020
136 DYSCHEZIA 6 0.0020
137 INSURANCE ISSUE 30 0.0020
138 INCREASED BRONCHIAL SECRETION 5 0.0020
139 GASTROSTOMY 3 0.0019
140 THINKING ABNORMAL 36 0.0019
141 VIRAL UPPER RESPIRATORY TRACT INFECTION 9 0.0019
142 IMPAIRED GASTRIC EMPTYING 25 0.0018
143 MEDICAL PROCEDURE 3 0.0018
144 TONSILLECTOMY 3 0.0018
145 SMALL INTESTINE CARCINOMA 4 0.0018
146 PRODUCT TEMPERATURE EXCURSION ISSUE 9 0.0017
147 ORAL PAIN 39 0.0017
148 ACUTE SINUSITIS 3 0.0017
149 CARBON DIOXIDE DECREASED 2 0.0017
150 ADMINISTRATION SITE PAIN 2 0.0017
151 THERAPY CHANGE 17 0.0017
152 NECK SURGERY 4 0.0017
153 PRODUCTIVE COUGH 82 0.0017
154 SINUS PAIN 4 0.0017
155 PULMONARY PAIN 5 0.0017
156 STRIDOR 5 0.0017
157 JAUNDICE CHOLESTATIC 6 0.0017
158 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
159 VOLVULUS 4 0.0017
160 SPUTUM DISCOLOURED 16 0.0017
161 FULL BLOOD COUNT INCREASED 2 0.0017
162 PRODUCT SIZE ISSUE 9 0.0017
163 COLON OPERATION 2 0.0017
164 BILE DUCT STENOSIS 2 0.0017
165 REBOUND ACID HYPERSECRETION 5 0.0017
166 EMERGENCY CARE 5 0.0016
167 CEREBRAL ARTERY EMBOLISM 2 0.0016
168 PNEUMOTHORAX 26 0.0016
169 ANEURYSM 8 0.0016
170 CHEMOTHERAPY 6 0.0016
171 TESTICULAR PAIN 5 0.0016
172 PARANASAL SINUS HYPERSECRETION 6 0.0016
173 BILE DUCT STONE 5 0.0016
174 ANAL INCONTINENCE 14 0.0016
175 RALES 9 0.0015
176 CATHETER SITE PAIN 4 0.0015
177 FAILURE TO THRIVE 8 0.0015
178 EPIGASTRIC DISCOMFORT 6 0.0015
179 VOCAL CORD DISORDER 3 0.0015
180 SNEEZING 34 0.0015
181 BRONCHIECTASIS 10 0.0015
182 EAR CONGESTION 4 0.0015
183 NIPPLE PAIN 3 0.0015
184 CARBON DIOXIDE INCREASED 2 0.0015
185 PRODUCT USE COMPLAINT 23 0.0015
186 CORNEAL ABRASION 2 0.0015
187 MALNUTRITION 16 0.0014
188 DEFAECATION URGENCY 10 0.0014
189 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
190 NASAL POLYPS 7 0.0014
191 RESPIRATORY SYMPTOM 4 0.0014
192 CATHETER SITE ERYTHEMA 3 0.0014
193 APPENDICECTOMY 5 0.0014
194 ABDOMINAL DISTENSION 143 0.0014
195 SINUS DISORDER 27 0.0014
196 PANCREATITIS 72 0.0014
197 COLONOSCOPY 3 0.0014
198 PANCREATIC CARCINOMA 39 0.0013
199 ACNE CYSTIC 4 0.0013
200 PROTEIN TOTAL DECREASED 5 0.0013
201 VARICES OESOPHAGEAL 4 0.0013
202 ASTIGMATISM 2 0.0013
203 CLAVICLE FRACTURE 5 0.0013
204 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
205 PORTAL HYPERTENSION 4 0.0013
206 BEHAVIOUR DISORDER 7 0.0013
207 WOUND 36 0.0013
208 BRONCHIAL DISORDER 2 0.0013
209 MUSCLE RUPTURE 5 0.0013
210 INFECTION 185 0.0013
211 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
212 OBSTRUCTION 5 0.0013
213 GASTROINTESTINAL OBSTRUCTION 3 0.0012
214 DERMAL CYST 3 0.0012
215 PANCREATITIS ACUTE 27 0.0012
216 IRON DEFICIENCY ANAEMIA 11 0.0012
217 FEEDING DISORDER 24 0.0012
218 ENTERITIS INFECTIOUS 2 0.0012
219 ILEOSTOMY 3 0.0012
220 LACTOSE INTOLERANCE 3 0.0012
221 LUNG DISORDER 57 0.0012
222 HERNIA REPAIR 3 0.0012
223 SMALL INTESTINAL OBSTRUCTION 14 0.0011
224 DEPRESSIVE SYMPTOM 4 0.0011
225 ANORECTAL DISCOMFORT 6 0.0011
226 ABDOMINAL MASS 3 0.0011
227 MYCOBACTERIUM AVIUM COMPLEX INFECTION 3 0.0011
228 HOSPICE CARE 11 0.0011
229 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
230 ESSENTIAL HYPERTENSION 2 0.0011
231 FOOD INTOLERANCE 4 0.0011
232 CONDUCTION DISORDER 2 0.0011
233 FREQUENT BOWEL MOVEMENTS 29 0.0011
234 BLOOD IRON INCREASED 2 0.0011
235 COLITIS MICROSCOPIC 5 0.0011
236 BILE DUCT OBSTRUCTION 2 0.0011
237 BOWEL MOVEMENT IRREGULARITY 8 0.0010
238 BLOOD MAGNESIUM DECREASED 9 0.0010
239 BLOOD URIC ACID INCREASED 6 0.0010
240 DYSPNOEA AT REST 3 0.0010
241 REHABILITATION THERAPY 4 0.0010
242 PRODUCT LABEL ISSUE 7 0.0010
243 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
244 WHEEZING 61 0.0010
245 FAECES HARD 4 0.0010
246 EARLY SATIETY 2 0.0010
247 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
248 NEPHROLITHIASIS 47 0.0010
249 VIRAL INFECTION 34 0.0010
250 PNEUMONIA FUNGAL 4 0.0010
251 OESOPHAGEAL PAIN 4 0.0010
252 DRUG EFFECT LESS THAN EXPECTED 15 0.0010
253 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
254 TYPE 1 DIABETES MELLITUS 6 0.0010
255 CENTRAL VENOUS CATHETERISATION 3 0.0010
256 SKIN DISORDER 33 0.0010
257 DUODENITIS 3 0.0010
258 ANAL PRURITUS 2 0.0010
259 CHOLECYSTECTOMY 11 0.0010
260 SLEEP TERROR 4 0.0009
261 INTENTIONAL DOSE OMISSION 27 0.0009
262 RHINORRHOEA 61 0.0009
263 OSTEOARTHRITIS 40 0.0009
264 PNEUMONIA VIRAL 3 0.0009
265 HEPATIC PAIN 4 0.0009
266 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
267 LIVER FUNCTION TEST INCREASED 20 0.0009
268 PRODUCT RESIDUE PRESENT 5 0.0009
269 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
270 HEPATIC LESION 4 0.0009
271 HORDEOLUM 4 0.0009
272 ABDOMINAL PAIN UPPER 189 0.0009
273 CONSTIPATION 200 0.0009
274 INFUSION SITE HAEMORRHAGE 3 0.0009
275 ANXIETY DISORDER 3 0.0009
276 TREATMENT NONCOMPLIANCE 49 0.0009
277 INCREASED APPETITE 17 0.0009
278 BLOOD LOSS ANAEMIA 2 0.0009
279 ABDOMINAL PAIN 205 0.0009
280 RESPIRATORY TRACT CONGESTION 14 0.0009
281 REGURGITATION 3 0.0009
282 LARGE INTESTINE POLYP 6 0.0009
283 NEPHROGENIC ANAEMIA 4 0.0009
284 PRODUCT DISTRIBUTION ISSUE 8 0.0009
285 RENAL FUNCTION TEST ABNORMAL 4 0.0009
286 HUNGER 12 0.0009
287 BACTERIAL INFECTION 16 0.0009
288 HEPATIC ENZYME INCREASED 58 0.0008
289 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
290 PULMONARY CONGESTION 11 0.0008
291 INFLUENZA 93 0.0008
292 BRAIN FOG 13 0.0008
293 ERUCTATION 16 0.0008
294 PRODUCT DISPENSING ERROR 18 0.0008
295 BREATH ODOUR 2 0.0008
296 VITAMIN D DEFICIENCY 8 0.0008
297 INCORRECT DOSAGE ADMINISTERED 4 0.0008
298 SPINAL OPERATION 10 0.0008
299 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
300 DYSPEPSIA 79 0.0008
301 WEIGHT DECREASED 222 0.0008
302 OEDEMA 43 0.0008
303 PRODUCT STORAGE ISSUE 3 0.0008
304 DRUG TOLERANCE 4 0.0008
305 ILL-DEFINED DISORDER 48 0.0008
306 THERAPY INTERRUPTED 56 0.0008
307 CANCER PAIN 2 0.0008
308 HYPOPHAGIA 20 0.0008
309 INCREASED UPPER AIRWAY SECRETION 4 0.0008
310 DIARRHOEA 500 0.0008
311 END STAGE RENAL DISEASE 14 0.0008
312 PULMONARY HAEMORRHAGE 6 0.0008
313 BLISTER 43 0.0008
314 WEIGHT FLUCTUATION 8 0.0008
315 PATENT DUCTUS ARTERIOSUS 3 0.0008
316 ALCOHOL ABUSE 2 0.0007
317 TERMINAL STATE 5 0.0007
318 BLOOD SODIUM DECREASED 14 0.0007
319 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
320 NECK PAIN 41 0.0007
321 STAPHYLOCOCCAL INFECTION 24 0.0007
322 GASTROINTESTINAL PAIN 8 0.0007
323 INTESTINAL ISCHAEMIA 4 0.0007
324 SOCIAL PROBLEM 3 0.0007
325 INTERSTITIAL LUNG DISEASE 35 0.0007
326 DRUG SCREEN FALSE POSITIVE 2 0.0007
327 THYROID FUNCTION TEST ABNORMAL 3 0.0007
328 PNEUMONIA 233 0.0007
329 SECRETION DISCHARGE 9 0.0007
330 RENAL TUBULAR NECROSIS 7 0.0007
331 ABDOMINAL DISCOMFORT 119 0.0007
332 TONGUE DISCOMFORT 3 0.0007
333 COUGH 198 0.0007
334 ANAPHYLACTIC REACTION 39 0.0007
335 PRODUCT SUPPLY ISSUE 5 0.0007
336 IRRITABLE BOWEL SYNDROME 15 0.0007
337 METASTATIC NEOPLASM 3 0.0007
338 EXERCISE TOLERANCE DECREASED 4 0.0007
339 ADENOVIRUS INFECTION 2 0.0007
340 FAECES SOFT 5 0.0007
341 BILIARY COLIC 2 0.0007
342 SINUSITIS 70 0.0007
343 GASTROINTESTINAL DISORDER 61 0.0007
344 CATHETERISATION CARDIAC 3 0.0007
345 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
346 SINUS CONGESTION 9 0.0007
347 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
348 EXPIRED PRODUCT ADMINISTERED 22 0.0007
349 VASCULAR DEVICE INFECTION 3 0.0007
350 PNEUMONIA BACTERIAL 6 0.0007
351 CANDIDA INFECTION 11 0.0007
352 FOOD ALLERGY 5 0.0006
353 BRAIN DEATH 2 0.0006
354 PHARYNGITIS STREPTOCOCCAL 7 0.0006
355 GASTRITIS 17 0.0006
356 GASTROOESOPHAGEAL REFLUX DISEASE 52 0.0006
357 CHOLANGITIS 4 0.0006
358 ROSACEA 3 0.0006
359 DYSPHAGIA 61 0.0006
360 EYELIDS PRURITUS 2 0.0006
361 TIBIA FRACTURE 3 0.0006
362 BLOOD CREATININE DECREASED 2 0.0006
363 SWELLING OF EYELID 4 0.0006
364 INFUSION SITE SWELLING 4 0.0006
365 BRAIN OEDEMA 8 0.0006
366 PRODUCT PACKAGING ISSUE 6 0.0006
367 BLOOD ALBUMIN DECREASED 5 0.0006
368 ENDOMETRIOSIS 3 0.0006
369 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
370 PROCTALGIA 4 0.0006
371 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
372 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
373 POLYP 4 0.0006
374 DEMENTIA 17 0.0006
375 DISABILITY 12 0.0006
376 WALKING AID USER 4 0.0006
377 MUCOUS STOOLS 3 0.0006
378 CHEST DISCOMFORT 62 0.0006
379 ABDOMINAL TENDERNESS 3 0.0006
380 EMBOLISM 5 0.0006
381 EAR INFECTION 16 0.0006
382 SKIN MASS 4 0.0006
383 CORONARY ARTERIAL STENT INSERTION 3 0.0006
384 AMMONIA INCREASED 3 0.0006
385 CACHEXIA 3 0.0006
386 CARDIAC OPERATION 5 0.0006
387 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
388 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
389 ORAL DISCOMFORT 8 0.0006
390 ACUTE RESPIRATORY FAILURE 11 0.0006
391 HERNIA 11 0.0006
392 ILEUS 7 0.0006
393 BRONCHOSPASM 8 0.0006
394 FOOD POISONING 3 0.0006
395 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
396 BLOOD BILIRUBIN INCREASED 15 0.0006
397 CONTUSION 53 0.0005
398 PRODUCT PHYSICAL ISSUE 11 0.0005
399 PRODUCT ADMINISTRATION ERROR 11 0.0005
400 ILLNESS 56 0.0005
401 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
402 BLOOD CALCIUM DECREASED 6 0.0005
403 HALLUCINATION 40 0.0005
404 MENTAL DISORDER 23 0.0005
405 FACE INJURY 2 0.0005
406 POST PROCEDURAL COMPLICATION 10 0.0005
407 ATELECTASIS 5 0.0005
408 RETCHING 11 0.0005
409 AUTOIMMUNE DISORDER 5 0.0005
410 CARDIOPULMONARY FAILURE 2 0.0005
411 HAEMORRHOIDS 10 0.0005
412 SURGERY 30 0.0005
413 MULTIPLE ALLERGIES 4 0.0005
414 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
415 KIDNEY INFECTION 10 0.0005
416 DECREASED INTEREST 3 0.0005
417 ENERGY INCREASED 3 0.0005
418 THERAPY CESSATION 26 0.0005
419 GALLBLADDER DISORDER 9 0.0005
420 PRODUCT STORAGE ERROR 44 0.0005
421 ODYNOPHAGIA 3 0.0005
422 BLEPHARITIS 2 0.0005
423 GANGRENE 3 0.0005
424 SEASONAL ALLERGY 7 0.0005
425 FOETAL GROWTH RESTRICTION 3 0.0005
426 CHOLELITHIASIS 16 0.0005
427 PIGMENTATION DISORDER 3 0.0005
428 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
429 EYE DISCHARGE 5 0.0005
430 LIP SWELLING 16 0.0005
431 FUNGAL INFECTION 16 0.0005
432 LIMB INJURY 13 0.0005
433 NASAL CONGESTION 28 0.0005
434 DRUG INTOLERANCE 46 0.0005
435 FOOT FRACTURE 9 0.0005
436 CHRONIC KIDNEY DISEASE 36 0.0005
437 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
438 RESPIRATORY DISTRESS 13 0.0005
439 PULMONARY MASS 7 0.0005
440 ABSCESS LIMB 2 0.0005
441 ENTERITIS 3 0.0005
442 LOWER LIMB FRACTURE 9 0.0005
443 VISUAL IMPAIRMENT 58 0.0005
444 INCOHERENT 3 0.0005
445 CHOKING 9 0.0005
446 FAECES DISCOLOURED 10 0.0005
447 CHAPPED LIPS 2 0.0005
448 SKIN LACERATION 5 0.0005
449 PRODUCT PRESCRIBING ISSUE 10 0.0005
450 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
451 DIVERTICULUM INTESTINAL 2 0.0005
452 ASPERGILLUS INFECTION 3 0.0005
453 SOMNAMBULISM 3 0.0005
454 NASOPHARYNGITIS 84 0.0005
455 JOINT SWELLING 55 0.0005
456 GRIP STRENGTH DECREASED 4 0.0005
457 DEPRESSED MOOD 24 0.0005
458 GASTROINTESTINAL INFECTION 4 0.0004
459 POSTOPERATIVE WOUND INFECTION 3 0.0004
460 GASTROENTERITIS VIRAL 8 0.0004
461 ABNORMAL LOSS OF WEIGHT 3 0.0004
462 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
463 INTERNAL HAEMORRHAGE 5 0.0004
464 ABDOMINAL PAIN LOWER 11 0.0004
465 EYE OPERATION 2 0.0004
466 MUSCULOSKELETAL STIFFNESS 38 0.0004
467 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
468 HEPATIC STEATOSIS 8 0.0004
469 PRODUCT DOSE OMISSION 28 0.0004
470 HEPATIC ENCEPHALOPATHY 4 0.0004
471 DYSPHONIA 25 0.0004
472 FLANK PAIN 4 0.0004
473 RESPIRATORY FAILURE 31 0.0004
474 HAND FRACTURE 3 0.0004
475 DIVERTICULUM 3 0.0004
476 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
477 EMOTIONAL DISORDER 13 0.0004
478 JOINT INJURY 9 0.0004
479 OROPHARYNGEAL PAIN 39 0.0004
480 METASTASIS 3 0.0004
481 DEHYDRATION 56 0.0004
482 CHILLS 49 0.0004
483 WEIGHT INCREASED 93 0.0004
484 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
485 GASTRIC DISORDER 14 0.0004
486 HEPATOMEGALY 4 0.0004
487 HEADACHE 255 0.0004
488 CARDIOMEGALY 5 0.0004
489 PSYCHIATRIC SYMPTOM 3 0.0004
490 PRODUCT USE ISSUE 76 0.0004
491 HIP FRACTURE 13 0.0004
492 DIABETIC NEUROPATHY 2 0.0004
493 COLON CANCER 6 0.0004
494 SUNBURN 3 0.0004
495 DECREASED APPETITE 93 0.0004
496 HEAD DISCOMFORT 7 0.0004
497 DRUG DISPENSING ERROR 6 0.0004
498 GOUT 7 0.0004
499 INITIAL INSOMNIA 4 0.0004
500 TEMPERATURE INTOLERANCE 4 0.0004
501 CONGENITAL ANOMALY 3 0.0004
502 HIATUS HERNIA 5 0.0004
503 HYPERBILIRUBINAEMIA 4 0.0004
504 PELVIC FRACTURE 3 0.0004
505 ANGER 13 0.0004
506 VOMITING 180 0.0004
507 TRANSFUSION 4 0.0004
508 AFFECTIVE DISORDER 3 0.0004
509 INCORRECT PRODUCT STORAGE 5 0.0004
510 BEDRIDDEN 5 0.0004
511 FOOD CRAVING 2 0.0004
512 ORAL CANDIDIASIS 5 0.0004
513 BLOOD GLUCOSE ABNORMAL 7 0.0004
514 RHEUMATOID ARTHRITIS 43 0.0004
515 SARS-COV-2 TEST POSITIVE 5 0.0004
516 FURUNCLE 3 0.0004
517 INCONTINENCE 4 0.0004
518 NASAL DISCOMFORT 3 0.0004
519 MIGRAINE 36 0.0004
520 MOOD SWINGS 12 0.0004
521 BLOOD GLUCOSE DECREASED 18 0.0004
522 ASCITES 11 0.0004
523 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
524 COMPRESSION FRACTURE 2 0.0004
525 HEPATIC CIRRHOSIS 7 0.0004
526 HYPOGLYCAEMIA 18 0.0004
527 BRUXISM 2 0.0004
528 DECREASED ACTIVITY 4 0.0004
529 BLOOD POTASSIUM INCREASED 6 0.0004
530 PRODUCT TASTE ABNORMAL 5 0.0004
531 HYPOXIA 13 0.0004
532 DECUBITUS ULCER 3 0.0004
533 HYPOAESTHESIA 55 0.0004
534 PRODUCT DOSE OMISSION ISSUE 108 0.0004
535 BACK PAIN 85 0.0004
536 ASPIRATION 4 0.0004
537 FAECALOMA 2 0.0004
538 ESCHERICHIA INFECTION 3 0.0004
539 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
540 DYSPNOEA 201 0.0004
541 SLEEP DISORDER 25 0.0004
542 COLECTOMY 2 0.0004
543 DYSURIA 13 0.0004
544 CHOLECYSTITIS ACUTE 2 0.0004
545 NAUSEA 279 0.0004
546 DIALYSIS 5 0.0004
547 CONDITION AGGRAVATED 107 0.0004
548 BRONCHITIS 26 0.0004
549 DERMATITIS CONTACT 4 0.0004
550 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
551 ANURIA 3 0.0003
552 HYPOACUSIS 15 0.0003
553 IMPAIRED QUALITY OF LIFE 5 0.0003
554 NO ADVERSE EVENT 63 0.0003
555 CARDIAC MURMUR 3 0.0003
556 HAEMATOCHEZIA 19 0.0003
557 DEAFNESS 9 0.0003
558 DEATH 296 0.0003
559 DEPRESSION 78 0.0003
560 COVID-19 60 0.0003
561 METASTASES TO LIVER 6 0.0003
562 PRODUCT COMMUNICATION ISSUE 3 0.0003
563 PURPURA 3 0.0003
564 RESPIRATORY RATE INCREASED 3 0.0003
565 FACIAL PAIN 3 0.0003
566 PULMONARY HYPERTENSION 7 0.0003
567 POLLAKIURIA 14 0.0003
568 ASTHENIA 126 0.0003
569 THROAT IRRITATION 15 0.0003
570 WRIST FRACTURE 4 0.0003
571 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
572 LIP DRY 3 0.0003
573 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
574 OSTEOPENIA 5 0.0003
575 MUSCULOSKELETAL CHEST PAIN 5 0.0003
576 PERSONALITY CHANGE 3 0.0003
577 ADVERSE DRUG REACTION 29 0.0003
578 DRY SKIN 43 0.0003
579 MALAISE 140 0.0003
580 BLEPHAROSPASM 2 0.0003
581 LUNG NEOPLASM MALIGNANT 13 0.0003
582 MUSCLE ATROPHY 4 0.0003
583 HYPERSOMNIA 9 0.0003
584 FOREIGN BODY SENSATION IN EYES 2 0.0003
585 RASH PRURITIC 17 0.0003
586 RASH PAPULAR 7 0.0003
587 DIZZINESS POSTURAL 3 0.0003
588 ANXIETY 88 0.0003
589 DYSSTASIA 9 0.0003
590 INTENTIONAL PRODUCT USE ISSUE 27 0.0003
591 CHEST PAIN 57 0.0003
592 RESPIRATORY TRACT INFECTION 8 0.0003
593 COELIAC DISEASE 3 0.0003
594 FATIGUE 238 0.0003
595 LIGAMENT SPRAIN 3 0.0003
596 GAIT DISTURBANCE 58 0.0003
597 CORONAVIRUS INFECTION 2 0.0003
598 CATARACT 18 0.0003
599 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
600 BLOOD PRESSURE ABNORMAL 6 0.0003
601 DIABETES MELLITUS 23 0.0003
602 ADVERSE REACTION 4 0.0003
603 OVARIAN CYST 3 0.0003
604 NEOPLASM MALIGNANT 20 0.0003
605 BLOOD POTASSIUM DECREASED 9 0.0003
606 GAIT INABILITY 10 0.0003
607 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
608 APHASIA 9 0.0003
609 CELLULITIS 15 0.0003
610 LOSS OF CONSCIOUSNESS 38 0.0003
611 HYPOTHERMIA 3 0.0003
612 TASTE DISORDER 6 0.0003
613 DRY THROAT 3 0.0003
614 MYALGIA 50 0.0003
615 LIVER DISORDER 13 0.0003
616 EUPHORIC MOOD 3 0.0003
617 RASH ERYTHEMATOUS 14 0.0003
618 ASTHMA 33 0.0003
619 RIB FRACTURE 6 0.0003
620 MEMORY IMPAIRMENT 40 0.0003
621 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
622 ACNE 22 0.0003
623 DROOLING 2 0.0003
624 RASH 126 0.0003
625 PYREXIA 100 0.0003
626 FORMICATION 2 0.0003
627 URINARY TRACT INFECTION 49 0.0003
628 ROAD TRAFFIC ACCIDENT 12 0.0003
629 APHONIA 4 0.0003
630 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
631 JOINT DISLOCATION 3 0.0003
632 DUODENAL ULCER 2 0.0003
633 RENAL PAIN 3 0.0003
634 EATING DISORDER 6 0.0003
635 BREAST PAIN 3 0.0003
636 THIRST 5 0.0003
637 ARTHRITIS 22 0.0003
638 PERIPHERAL SWELLING 43 0.0003
639 RENAL DISORDER 13 0.0003
640 POOR QUALITY SLEEP 6 0.0003
641 LEUKOCYTOSIS 5 0.0003
642 HYPOKINESIA 4 0.0003
643 PULMONARY THROMBOSIS 3 0.0003
644 RESTLESS LEGS SYNDROME 5 0.0003
645 PANIC ATTACK 10 0.0003
646 BLOOD GLUCOSE FLUCTUATION 3 0.0003
647 BLINDNESS TRANSIENT 2 0.0003
648 RENAL FAILURE 36 0.0003
649 DIZZINESS 135 0.0003
650 RASH GENERALISED 7 0.0003
651 ARTHROPOD BITE 2 0.0003
652 ARTHRALGIA 112 0.0003
653 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
654 RESPIRATORY DISORDER 8 0.0003
655 OXYGEN SATURATION DECREASED 15 0.0003
656 JOINT STIFFNESS 7 0.0003
657 CHROMATURIA 6 0.0003
658 EYE INFECTION 3 0.0003
659 GASTRIC ULCER 5 0.0003
660 FEELING ABNORMAL 63 0.0003
661 PRURITUS 101 0.0003
662 MICTURITION URGENCY 3 0.0003
663 ACIDOSIS 2 0.0003
664 TINNITUS 12 0.0003
665 DISSOCIATION 2 0.0003
666 DRUG PRESCRIBING ERROR 5 0.0003
667 NIGHTMARE 9 0.0003
668 DEVICE RELATED INFECTION 4 0.0003
669 THYROID DISORDER 4 0.0003
670 CONCUSSION 2 0.0003
671 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
672 APNOEA 2 0.0003
673 SPLENOMEGALY 3 0.0003
674 FLUID RETENTION 13 0.0003
675 EPISTAXIS 19 0.0003
676 DRUG SCREEN POSITIVE 2 0.0003
677 HEAD INJURY 8 0.0003
678 PAIN 155 0.0003
679 PRODUCT PRESCRIBING ERROR 6 0.0003
680 MACULAR DEGENERATION 3 0.0003
681 HYPERLIPIDAEMIA 3 0.0003
682 SEPSIS 28 0.0003
683 UPPER LIMB FRACTURE 5 0.0003
684 DIABETIC KETOACIDOSIS 6 0.0002
685 SPINAL FRACTURE 5 0.0002
686 IRRITABILITY 15 0.0002
687 NIGHT SWEATS 8 0.0002
688 ERYTHEMA 51 0.0002
689 FRUSTRATION TOLERANCE DECREASED 2 0.0002
690 MENTAL IMPAIRMENT 6 0.0002
691 NOCTURIA 3 0.0002
692 BLOOD GLUCOSE INCREASED 46 0.0002
693 MANIA 4 0.0002
694 DRUG DOSE OMISSION 40 0.0002
695 EYE SWELLING 9 0.0002
696 PHARYNGITIS 3 0.0002
697 PERITONITIS 5 0.0002
698 UNEVALUABLE EVENT 18 0.0002
699 ACUTE KIDNEY INJURY 36 0.0002
700 MUSCLE SPASMS 43 0.0002
701 PARANOIA 4 0.0002
702 STOMATITIS 14 0.0002
703 SYRINGE ISSUE 4 0.0002
704 ANHEDONIA 6 0.0002
705 MELAENA 5 0.0002
706 LIMB DISCOMFORT 7 0.0002
707 LETHARGY 13 0.0002
708 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
709 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
710 SEIZURE 26 0.0002
711 DRY MOUTH 18 0.0002
712 MOOD ALTERED 6 0.0002
713 GINGIVAL BLEEDING 3 0.0002
714 PERIPHERAL COLDNESS 3 0.0002
715 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
716 PROCEDURAL PAIN 6 0.0002
717 CONJUNCTIVITIS 4 0.0002
718 HYPOMAGNESAEMIA 3 0.0002
719 MASS 3 0.0002
720 CARPAL TUNNEL SYNDROME 3 0.0002
721 MIDDLE INSOMNIA 4 0.0002
722 DIARRHOEA HAEMORRHAGIC 2 0.0002
723 BURNING SENSATION 15 0.0002
724 OFF LABEL USE 187 0.0002
725 BLOOD TEST ABNORMAL 3 0.0002
726 CEREBROVASCULAR ACCIDENT 36 0.0002
727 DYSPNOEA EXERTIONAL 8 0.0002
728 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
729 URINARY RETENTION 7 0.0002
730 SLEEP APNOEA SYNDROME 4 0.0002
731 EXPOSURE DURING PREGNANCY 13 0.0002
732 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
733 SUICIDAL IDEATION 19 0.0002
734 MYELODYSPLASTIC SYNDROME 3 0.0002
735 LIVER FUNCTION TEST ABNORMAL 6 0.0002
736 FIBROMYALGIA 5 0.0002
737 PRESYNCOPE 5 0.0002
738 GASTROENTERITIS 3 0.0002
739 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
740 BONE PAIN 12 0.0002
741 FALL 68 0.0002
742 BODY TEMPERATURE DECREASED 2 0.0002
743 DISEASE PROGRESSION 24 0.0002
744 URINARY INCONTINENCE 6 0.0002
745 SKIN HAEMORRHAGE 3 0.0002
746 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 41 0.0002
747 RENAL INJURY 6 0.0002
748 HAEMATOCRIT DECREASED 4 0.0002
749 PRESCRIBED UNDERDOSE 4 0.0002
750 SWELLING FACE 13 0.0002
751 INTENTIONAL SELF-INJURY 4 0.0002
752 HAEMATEMESIS 5 0.0002
753 DISCOMFORT 12 0.0002
754 INSOMNIA 52 0.0002
755 ATRIAL FIBRILLATION 19 0.0002
756 OSTEOPOROSIS 8 0.0002
757 INTENTIONAL PRODUCT MISUSE 17 0.0002
758 TENDONITIS 3 0.0002
759 CRYING 7 0.0002
760 SPEECH DISORDER 10 0.0002
761 HALLUCINATION, VISUAL 4 0.0002
762 HALLUCINATION, AUDITORY 3 0.0002
763 CYSTITIS 6 0.0002
764 SCIATICA 3 0.0002
765 ABSCESS 3 0.0002
766 SKIN CANCER 4 0.0002
767 HOT FLUSH 14 0.0002
768 PAIN OF SKIN 5 0.0002
769 COLITIS 7 0.0002
770 BACK DISORDER 3 0.0002
771 AMNESIA 12 0.0002
772 BIPOLAR DISORDER 2 0.0002
773 BACK INJURY 2 0.0002
774 BLOOD CREATININE INCREASED 12 0.0002
775 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
776 METASTASES TO BONE 3 0.0002
777 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
778 HEART RATE INCREASED 18 0.0002
779 PHOTOSENSITIVITY REACTION 3 0.0002
780 DENTAL CARIES 2 0.0002
781 DIVERTICULITIS 5 0.0002
782 TRANSAMINASES INCREASED 4 0.0002
783 AGGRESSION 9 0.0002
784 FEELING HOT 11 0.0002
785 URTICARIA 30 0.0002
786 NEUROPATHY PERIPHERAL 17 0.0002
787 PULMONARY OEDEMA 8 0.0002
788 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
789 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
790 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
791 HYPONATRAEMIA 10 0.0002
792 HEMIPARESIS 3 0.0002
793 MUSCULAR WEAKNESS 20 0.0002
794 PRODUCT AVAILABILITY ISSUE 4 0.0002
795 MUSCULOSKELETAL DISCOMFORT 3 0.0002
796 CONFUSIONAL STATE 28 0.0002
797 ELECTROLYTE IMBALANCE 2 0.0002
798 ECZEMA 9 0.0002
799 BLINDNESS 7 0.0002
800 RASH MACULAR 6 0.0002
801 COGNITIVE DISORDER 8 0.0002
802 LABORATORY TEST ABNORMAL 5 0.0002
803 DEEP VEIN THROMBOSIS 11 0.0002
804 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
805 BLOOD IRON DECREASED 2 0.0002
806 BACTERAEMIA 2 0.0002
807 VISION BLURRED 23 0.0002
808 ACCIDENT 2 0.0002
809 PREMATURE BABY 5 0.0002
810 INFUSION RELATED REACTION 11 0.0002
811 HEPATIC FAILURE 5 0.0002
812 ADRENAL INSUFFICIENCY 2 0.0002
813 BONE DISORDER 3 0.0002
814 HYPOTENSION 33 0.0002
815 ACCIDENTAL OVERDOSE 6 0.0002
816 BLOOD PRESSURE INCREASED 25 0.0002
817 RECTAL HAEMORRHAGE 7 0.0002
818 ENCEPHALOPATHY 4 0.0002
819 PALPITATIONS 19 0.0002
820 DYSGEUSIA 12 0.0002
821 DRY EYE 8 0.0002
822 SOMNOLENCE 32 0.0002
823 DRUG INEFFECTIVE 209 0.0002
824 HERPES ZOSTER 9 0.0002
825 METABOLIC ACIDOSIS 5 0.0002
826 PAIN IN EXTREMITY 46 0.0002
827 HAEMOGLOBIN DECREASED 16 0.0002
828 PRESCRIBED OVERDOSE 3 0.0002
829 UNRESPONSIVE TO STIMULI 4 0.0002
830 DIPLOPIA 4 0.0002
831 ORAL HERPES 3 0.0002
832 SEDATION 4 0.0002
833 EYE DISORDER 5 0.0002
834 ANAEMIA 29 0.0002
835 ADVERSE EVENT 14 0.0002
836 HYPOKALAEMIA 7 0.0002
837 DYSMENORRHOEA 2 0.0002
838 BLOOD PRESSURE DECREASED 10 0.0002
839 EYE PRURITUS 5 0.0001
840 TYPE 2 DIABETES MELLITUS 5 0.0001
841 EXTRA DOSE ADMINISTERED 6 0.0001
842 THROAT TIGHTNESS 4 0.0001
843 BODY TEMPERATURE INCREASED 3 0.0001
844 PNEUMONITIS 4 0.0001
845 INFLUENZA LIKE ILLNESS 12 0.0001
846 TOOTH LOSS 3 0.0001
847 MENTAL STATUS CHANGES 4 0.0001
848 ARTHROPATHY 8 0.0001
849 DERMATITIS 3 0.0001
850 HEART RATE DECREASED 5 0.0001
851 DEVICE OCCLUSION 2 0.0001
852 BLINDNESS UNILATERAL 2 0.0001
853 LYMPHADENOPATHY 5 0.0001
854 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
855 IMPAIRED WORK ABILITY 3 0.0001
856 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
857 HYPERSENSITIVITY 26 0.0001
858 SYNCOPE 14 0.0001
859 RED BLOOD CELL COUNT DECREASED 4 0.0001
860 HYPERHIDROSIS 18 0.0001
861 OEDEMA PERIPHERAL 17 0.0001
862 EYE IRRITATION 8 0.0001
863 ACCIDENTAL UNDERDOSE 2 0.0001
864 PRODUCT SUBSTITUTION ISSUE 8 0.0001
865 SWELLING 13 0.0001
866 FLUSHING 14 0.0001
867 HYPERGLYCAEMIA 5 0.0001
868 UNDERDOSE 10 0.0001
869 PSYCHOTIC DISORDER 4 0.0001
870 TOOTH DISORDER 3 0.0001
871 RASH MACULO-PAPULAR 3 0.0001
872 GLOSSODYNIA 3 0.0001
873 NERVOUSNESS 7 0.0001
874 DYSARTHRIA 5 0.0001
875 TREMOR 22 0.0001
876 LACRIMATION INCREASED 4 0.0001
877 ECONOMIC PROBLEM 2 0.0001
878 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
879 SKIN EXFOLIATION 11 0.0001
880 MUSCLE TWITCHING 3 0.0001
881 PERICARDIAL EFFUSION 3 0.0001
882 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
883 DELUSION 2 0.0001
884 CARDIAC DISORDER 12 0.0001
885 BASAL CELL CARCINOMA 2 0.0001
886 NERVOUS SYSTEM DISORDER 4 0.0001
887 SWOLLEN TONGUE 4 0.0001
888 DRUG-INDUCED LIVER INJURY 4 0.0001
889 OCULAR HYPERAEMIA 6 0.0001
890 ABNORMAL BEHAVIOUR 5 0.0001
891 MULTIPLE SCLEROSIS 6 0.0001
892 CARDIAC FAILURE 10 0.0001
893 THROMBOSIS 10 0.0001
894 EYE PAIN 7 0.0001
895 LOCALISED INFECTION 3 0.0001
896 TACHYCARDIA 11 0.0001
897 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
898 NEURALGIA 3 0.0001
899 PLATELET COUNT DECREASED 13 0.0001
900 BLOOD UREA INCREASED 2 0.0001
901 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
902 DRUG RESISTANCE 3 0.0001
903 INFLAMMATION 6 0.0001
904 SKIN ULCER 3 0.0001
905 EMOTIONAL DISTRESS 14 0.0001
906 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
907 VERTIGO 7 0.0001
908 HAEMORRHAGE 12 0.0001
909 COLD SWEAT 2 0.0001
910 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
911 ALOPECIA 22 0.0001
912 DISTURBANCE IN ATTENTION 6 0.0001
913 PALLOR 3 0.0001
914 SKIN LESION 3 0.0001
915 SKIN DISCOLOURATION 5 0.0001
916 ABNORMAL DREAMS 3 0.0001
917 INJECTION SITE MASS 4 0.0001
918 MEDICATION ERROR 6 0.0001
919 FEELING COLD 3 0.0001
920 BLOOD CHOLESTEROL INCREASED 5 0.0001
921 PAIN IN JAW 3 0.0001
922 ARRHYTHMIA 5 0.0001
923 BLOOD URINE PRESENT 2 0.0001
924 INCORRECT DOSE ADMINISTERED 24 0.0001
925 DISEASE RECURRENCE 5 0.0001
926 HYPERTENSION 22 0.0001
927 PLASMA CELL MYELOMA 4 0.0001
928 DISORIENTATION 4 0.0001
929 ABORTION SPONTANEOUS 4 0.0001
930 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
931 EPILEPSY 3 0.0001
932 MOBILITY DECREASED 7 0.0001
933 FEMUR FRACTURE 3 0.0001
934 RHABDOMYOLYSIS 4 0.0001
935 BONE DENSITY DECREASED 3 0.0001
936 PRODUCT QUALITY ISSUE 13 0.0001
937 RENAL IMPAIRMENT 8 0.0001
938 HYPOTHYROIDISM 3 0.0001
939 BALANCE DISORDER 8 0.0001
940 VAGINAL HAEMORRHAGE 4 0.0001
941 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
942 INJECTION SITE PRURITUS 6 0.0001
943 PARAESTHESIA 14 0.0001
944 SKIN IRRITATION 4 0.0001
945 CARDIAC FAILURE CONGESTIVE 7 0.0001
946 HYPERKALAEMIA 3 0.0001
947 PULMONARY EMBOLISM 8 0.0001
948 PRODUCT ADHESION ISSUE 3 0.0001
949 SKIN BURNING SENSATION 6 0.0001
950 PLEURAL EFFUSION 5 0.0001
951 CEREBRAL INFARCTION 2 0.0001
952 AGITATION 6 0.0001
953 THROMBOCYTOPENIA 9 0.0001
954 AGEUSIA 2 0.0001
955 INJECTION SITE SWELLING 6 0.0001
956 DEVICE ISSUE 7 0.0001
957 ANAPHYLACTIC SHOCK 2 0.0001
958 MUSCULOSKELETAL PAIN 4 0.0001
959 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
960 DEVICE MALFUNCTION 5 0.0001
961 ANGINA PECTORIS 2 0.0001
962 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
963 SEPTIC SHOCK 3 0.0001
964 DRUG WITHDRAWAL SYNDROME 6 0.0001
965 ACUTE MYOCARDIAL INFARCTION 2 0.0001
966 COLITIS ULCERATIVE 3 0.0001
967 SUICIDE ATTEMPT 4 0.0001
968 BREAST CANCER 6 0.0001
969 MYOCARDIAL INFARCTION 11 0.0001
970 DRUG INTERACTION 10 0.0001
971 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
972 CARDIAC ARREST 5 0.0001
973 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
974 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
975 DRUG EFFECT INCOMPLETE 2 0.0001
976 CONVULSION 3 0.0001
977 INJECTION SITE HAEMORRHAGE 4 0.0001
978 PROSTATE CANCER 4 0.0000
979 THERAPEUTIC RESPONSE DECREASED 3 0.0000
980 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
981 DEVICE LEAKAGE 2 0.0000
982 DEVICE DISLOCATION 2 0.0000
983 NEUTROPENIA 6 0.0000
984 INJECTION SITE REACTION 3 0.0000
985 INJECTION SITE PAIN 12 0.0000
986 FEBRILE NEUTROPENIA 2 0.0000
987 DRUG DOSE OMISSION BY DEVICE 2 0.0000
988 COMPLETED SUICIDE 2 0.0000
989 OVERDOSE 5 0.0000